Milliman Healthcare Inflation Plus ETF MHIP | AMEX

$20.37 -$0.30 | -1.45%
TREND SIGNAL:Signal available — unlock to view |2026-11-19

Company Overview:

Market Cap: $1.01M
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $19.45 - $23.78

0.6 Year MHIP Performance Metrics:

Total Return (with DRIP): 2.9% (4.99% CAGR)
Total Return (no DRIP): 2.9% (4.99% CAGR)
Share Price: 2.9% (4.99% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $10,288
Total Return $ (with DRIP): $288
MHIP Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
MHIP Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Compare stocks side-by-side

Projected Future Returns & Dividends for MHIP

Based on past 0.6-year performance, here are MHIP growth metrics:

Share price CAGR of +4.84%
Dividend CAGR of +0%

Using MHIP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

MHIP (DRIP)MHIP - No DRIP
Current Price$20.37$20.37
Start Shares490.92490.92
Start Value$10,000$10,000
  
After 10 years:
Final Share Count490.92490.92
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$20.37$20.37
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - MHIP

NOTE: Above numbers are our estimate based on MHIP's Dividend and Price CAGR over past 0.6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Milliman Healthcare Inflation Plus ETF (MHIP) had its IPO on 2026-04-21, and is traded on AMEX stock exchange.

The Milliman Healthcare Inflation Plus ETF (MHIP) is designed to shield and enhance investors' purchasing power against the backdrop of escalating medical expenditures. This is accomplished by leveraging proprietary actuarial data and sophisticated quantitative modeling. The fund’s analytical framework relies on Milliman's extensive database of actual healthcare claims, encompassing approximately 35 million insured individuals, to project future healthcare inflation through the examination of medical and pharmacy cost trajectories. Its investment portfolio encompasses both equity and fixed income securities spanning the entire healthcare supply chain, augmented by various inflation-hedging instruments such as commodities, Treasury Inflation-Protected Securities (TIPS), and conventional Treasury bonds. Typically, the MHIP portfolio undergoes monthly rebalancing, guided by a quantitative model that dynamically adjusts to shifts in US healthcare cost inflation. Specifically, the strategy increases its exposure to equities and commodities during periods of elevated inflation, conversely pivoting towards debt instruments when inflation levels are lower. The fund's holdings may further include derivative products like swaps, options, and futures contracts, as well as exchange-traded funds (ETFs).

MHIP website: https://www.millimanfunds.com


Loading signals…

DCF model unavailable for MHIP — no fundamentals on file (ETFs and funds are not modelable).